Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.
Welles L, Saville MW, Lietzau J, Pluda JM, Wyvill KM, Feuerstein I, Figg WD, Lush R, Odom J, Wilson WH, Fajardo MT, Humphrey RW, Feigal E, Tuck D, Steinberg SM, Broder S, Yarchoan R.
Welles L, et al.
J Clin Oncol. 1998 Mar;16(3):1112-21. doi: 10.1200/JCO.1998.16.3.1112.
J Clin Oncol. 1998.
PMID: 9508198
Clinical Trial.